Related Experiment Video
Updated: Apr 27, 2026

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
Membrane-Type 1 Matrix Metalloproteinase Downregulates Fibroblast Growth Factor-2 Binding to the Cell Surface and
Evelyne Tassone1, Cristina Valacca1, Paolo Mignatti1,2
1Department of Cardiothoracic Surgery, New York University School of Medicine, New York.
Abstract:
Membrane-type 1 matrix metalloproteinase (MT1-MMP, MMP-14), a transmembrane proteinase with an extracellular catalytic domain and a short cytoplasmic tail, degrades extracellular matrix components and controls diverse cell functions through proteolytic and non-proteolytic interactions with extracellular, intracellular, and transmembrane proteins. Here we show that in tumor cells MT1-MMP downregulates fibroblast growth factor-2 (FGF-2) signaling by reducing the amount of FGF-2 bound to the cell surface with high and low affinity. FGF-2 induces weaker activation of ERK1/2 MAP kinase in MT1-MMP expressing cells than in cells devoid of MT1-MMP. This effect is abolished in cells that express proteolytically inactive MT1-MMP but persists in cells expressing MT1-MMP mutants devoid of hemopexin-like or cytoplasmic domain, showing that FGF-2 signaling is downregulated by MT1-MMP proteolytic activity. MT1-MMP expression results in downregulation of FGFR-1 and -4, and in decreased amount of cell surface-associated FGF-2. In addition, MT1-MMP strongly reduces the amount of FGF-2 bound to the cell surface with low affinity. Because FGF-2 association with low-affinity binding sites is a prerequisite for binding to its high-affinity receptors, downregulation of low-affinity binding to the cell surface results in decreased FGF-2 signaling. Consistent with this conclusion, FGF-2 induction of tumor cell migration and invasion in vitro is stronger in cells devoid of MT1- MMP than in MT1-MMP expressing cells. Thus, MT1-MMP controls FGF-2 signaling by a proteolytic mechanism that decreases the cell's biological response to FGF-2.
Insights
Membrane-type 1 matrix metalloproteinase (MT1-MMP) degrades fibroblast growth factor-2 (FGF-2) on tumor cell surfaces. This proteolytic action reduces FGF-2 signaling, impacting cell migration and invasion.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Membrane-type 1 matrix metalloproteinase (MT1-MMP, MMP-14) is a transmembrane proteinase involved in extracellular matrix degradation and cell function regulation.
- Fibroblast growth factor-2 (FGF-2) signaling plays a crucial role in various cellular processes, including tumor growth and metastasis.
Purpose of the Study:
- To investigate the mechanism by which MT1-MMP influences FGF-2 signaling in tumor cells.
- To determine the role of MT1-MMP's proteolytic activity in regulating FGF-2 binding and downstream signaling.
Main Methods:
- Assessing FGF-2 binding to cell surfaces in MT1-MMP expressing and non-expressing tumor cells.
- Analyzing ERK1/2 MAP kinase activation in response to FGF-2 stimulation.
- Evaluating the impact of MT1-MMP mutations (proteolytically inactive, hemopexin-like domain-deleted, cytoplasmic domain-deleted) on FGF-2 signaling.
- Measuring FGFR-1 and -4 expression levels.
- Quantifying cell surface-associated FGF-2 at low and high affinity binding sites.
- Assessing FGF-2-induced tumor cell migration and invasion in vitro.
Main Results:
- MT1-MMP expression downregulates FGF-2 signaling by reducing cell surface-bound FGF-2, particularly at low-affinity sites.
- Proteolytic activity of MT1-MMP is essential for the downregulation of FGF-2 signaling, as inactive mutants do not exhibit this effect.
- MT1-MMP expression leads to decreased activation of ERK1/2 MAP kinase upon FGF-2 stimulation.
- Downregulation of FGFR-1 and -4 expression was observed in MT1-MMP expressing cells.
- MT1-MMP significantly reduces tumor cell migration and invasion induced by FGF-2.
Conclusions:
- MT1-MMP exerts proteolytic control over FGF-2 signaling by diminishing FGF-2 binding to low-affinity sites on the cell surface.
- This downregulation of FGF-2 binding ultimately leads to decreased cellular responses, including reduced migration and invasion.
- MT1-MMP's proteolytic activity is a key mechanism for modulating FGF-2-driven biological processes in tumor cells.
Related Concept Videos
TGF - β Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Role of Matrix Metalloproteases in Degradation of ECM
Cell-matrix's Response to Mechanical Forces
Anchoring junctions mechanically attach a cell to the...
Regulation of Angiogenesis and Blood Supply

